In October 2025, Abbott Laboratories reported third-quarter results showing US$11.37 billion in sales and reaffirmed its 2025 earnings guidance, narrowing expected full-year adjusted diluted EPS to ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
StockStory.org on MSN
1 Safe-and-Steady Stock with Exciting Potential and 2 We Question
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes ...
In an unpredictable market that shifts between greed and fear, income investors who own Dividend Kings sleep better at night, ...
The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...
4don MSN
Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience
Benchmark anticipates that Abbott’s Diagnostics business will pick up speed again in 2026 with the introduction of a new ...
Walmart will become the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in ...
Get the latest healthcare stock updates, key pharma deals, and major legal developments impacting the S&P 500.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback